As of 2025-09-16, the Relative Valuation of Medicenna Therapeutics Corp (MDNA.TO) is (0.19) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.06 CAD, the upside of Medicenna Therapeutics Corp based on Relative Valuation is -117.8%.
The range of the Relative Valuation is (0.36) - (0.12) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.3x - 3.5x | 2.9x |
| Forward P/E multiples | -1.8x - 0.8x | -0.5x |
| Fair Price | (0.36) - (0.12) | (0.19) |
| Upside | -134.4% - -111.3% | -117.8% |
| Date | P/E |
| 2025-09-11 | -6.62 |
| 2025-09-10 | -6.62 |
| 2025-09-09 | -6.75 |
| 2025-09-08 | -6.75 |
| 2025-09-05 | -6.69 |
| 2025-09-04 | -6.75 |
| 2025-09-03 | -6.62 |
| 2025-09-02 | -6.75 |
| 2025-08-29 | -6.94 |
| 2025-08-28 | -6.69 |
| 2025-08-27 | -6.88 |
| 2025-08-26 | -7.13 |
| 2025-08-25 | -7.26 |
| 2025-08-22 | -7.01 |
| 2025-08-21 | -7.13 |
| 2025-08-20 | -6.94 |
| 2025-08-19 | -6.81 |
| 2025-08-18 | -6.62 |
| 2025-08-15 | -6.88 |
| 2025-08-14 | -6.88 |
| 2025-08-13 | -6.37 |
| 2025-08-12 | -6.75 |
| 2025-08-11 | -7.07 |
| 2025-08-08 | -7.58 |
| 2025-08-07 | -6.43 |
| 2025-08-06 | -6.24 |
| 2025-08-05 | -5.73 |
| 2025-08-01 | -5.35 |
| 2025-07-31 | -5.35 |
| 2025-07-30 | -5.48 |
| 2025-07-29 | -5.41 |
| 2025-07-28 | -5.16 |
| 2025-07-25 | -5.35 |
| 2025-07-24 | -5.29 |
| 2025-07-23 | -5.41 |
| 2025-07-22 | -5.16 |
| 2025-07-21 | -5.10 |
| 2025-07-18 | -5.35 |
| 2025-07-17 | -5.60 |
| 2025-07-16 | -5.54 |
| 2025-07-15 | -5.29 |
| 2025-07-14 | -5.29 |
| 2025-07-11 | -5.35 |
| 2025-07-10 | -5.48 |
| 2025-07-09 | -5.60 |
| 2025-07-08 | -5.54 |
| 2025-07-07 | -5.48 |
| 2025-07-04 | -5.80 |
| 2025-07-03 | -5.73 |
| 2025-07-02 | -5.54 |